| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047883225 |
| P356 | DOI | 10.1023/A:1007058008477 |
| P698 | PubMed publication ID | 10789829 |
| P2093 | author name string | Z Vogel | |
| Y Sarne | |||
| M Shapira | |||
| P2860 | cites work | Cloning of a delta opioid receptor by functional expression | Q28213132 |
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Evidence for opioid receptor-mediated activation of the G-proteins, Go and Gi2, in membranes of neuroblastoma x glioma (NG108-15) hybrid cells | Q28241740 | ||
| Multiple opioid receptors: ligand selectivity profiles and binding site signatures | Q28342867 | ||
| Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C | Q28570988 | ||
| G Proteins and Opioid Receptor-Mediated Signalling | Q28608943 | ||
| Activation of Type II Adenylyl Cyclase by the Cloned μ‐Opioid Receptor: Coupling to Multiple G Proteins | Q28646197 | ||
| Opioid receptor-coupled second messenger systems | Q37179761 | ||
| Cloning and pharmacological characterization of a rat mu opioid receptor | Q38314662 | ||
| Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2 | Q38341212 | ||
| Cannabinoid receptor genes | Q40947685 | ||
| Regulation of multiple effectors by the cloned delta-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase. | Q41338715 | ||
| Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. | Q41353856 | ||
| Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells | Q41627574 | ||
| Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes | Q42436344 | ||
| Dissociation between the inhibitory and stimulatory effects of opioid peptides on cAMP formation in SK-N-SH neuroblastoma cells | Q42455636 | ||
| Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells | Q42461152 | ||
| Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits. | Q44335124 | ||
| Gz coupling to the rat kappa-opioid receptor | Q44336007 | ||
| Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density | Q44337785 | ||
| Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors | Q44338609 | ||
| mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells | Q44339787 | ||
| Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. | Q44340361 | ||
| Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum | Q44343153 | ||
| A human neuroblastoma cell line expresses mu and delta opioid receptor sites. | Q44346540 | ||
| An assessment of the role of opioid receptors in the response to cannabimimetic drugs. | Q44346742 | ||
| The GTP-binding protein, Go, regulates neuronal calcium channels | Q44508440 | ||
| Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase | Q48251232 | ||
| Identification of cannabinoid receptors in cultures of rat cerebellar granule cells. | Q48332522 | ||
| Opioids potentiate transmitter release from SK-N-SH human neuroblastoma cells by modulating N-type calcium channels | Q48643365 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. | Q48658239 | ||
| Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. | Q52400535 | ||
| Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. | Q55487809 | ||
| Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18tG2 and neuroblastoma x glioma NG108-15 hybrid cell lines. | Q55489922 | ||
| A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 | Q61776058 | ||
| Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes | Q69263069 | ||
| P433 | issue | 3 | |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| opioid | Q427523 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 291-304 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Cellular and Molecular Neurobiology | Q2333197 |
| P1476 | title | Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors | |
| P478 | volume | 20 |
| Q30420969 | A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling. |
| Q28270589 | AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies |
| Q24633877 | Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes |
| Q41668062 | Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex. |
| Q35047694 | CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat |
| Q42258726 | CB1 receptors modulate the intake of a sweetened-fat diet in response to μ-opioid receptor stimulation of the nucleus accumbens |
| Q42054026 | Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results? |
| Q41918324 | Divers pathways mediate delta-opioid receptor down regulation within the same cell |
| Q34489831 | Endogenous opiates: 2000. |
| Q38235155 | Endothelial atypical cannabinoid receptor: do we have enough evidence? |
| Q44342705 | Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors |
| Q40388658 | Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form. |
| Q44343235 | Functional analysis of MOR‐1 splice variants of the mouse mu opioid receptor gene Oprm |
| Q34701089 | Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot |
| Q30828780 | Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play. |
| Q28298445 | International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ |
| Q34674584 | Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice. |
| Q40680337 | Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation |
| Q37062556 | Molecular Pharmacology of δ-Opioid Receptors |
| Q28344890 | Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells |
| Q47754729 | Multiple mechanisms of CB1 cannabinoid receptors regulation |
| Q44338917 | Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia |
| Q37617453 | Signal transduction via cannabinoid receptors |
Search more.